Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-11 02:37:10 EDT

Explore

PostsPeople
LatestRanked
@asipath.bsky.socialSep 24, 2026, 1:04 PM

You don't want to miss the first virtual event for the Summer Liver Academy Meeting (SLAM) Community. Join us on October 15 for a fantastic talk from Dr. Zhenghui Jiang https://bit.ly/3V6iIet

#SLAM #LiverResearch #MASLD #ALD #Hepatology @harvardmed.bsky.social

@aasldnews.bsky.socialSep 24, 2026, 11:16 AM

This #HispanicHeritageMonth, join AASLD experts Monica Tincopa, MD, MSc and Blanca Lizaola-Mayo, MD to discuss #healthdisparities and opportunities to improve #MASLD and #MASH care in Latino communities.

🔗 Register to attend: https://bit.ly/4jkG9uA

@lancetrh-europe.bsky.socialSep 23, 2026, 5:04 PM

As the causes of #HCC change, so must Europe’s response.

Our Series explores how #MASLD, alcohol-related liver disease, and an ageing population are reshaping prevention, early detection, clinical practice, and health policy.

@liversmdpi.bsky.socialSep 23, 2026, 10:28 AM

📢 New Review in #LiversMDPI

🧬 Kaur et al. review PPAR agonists across PBC and other liver diseases.

🩺 The review covers molecular pharmacology and clinical and preclinical evidence.

📖 Read More: www.mdpi.com/2673-4389/6/...

#PPARAgonist #PBC #MASLD #Fibrosis

@bcmfromthelabs.bsky.socialSep 22, 2026, 5:16 PM

Are you following the current information on the epidemiology, pathophysiology, and treatment of #MASLD? Check out the recent #review by R. Xu et al here www.ccjm.org/content/93/9... @bcmhouston.bsky.social

@aasldnews.bsky.socialSep 21, 2026, 12:52 PM

An estimated 1.3B people worldwide were living with MASLD in 2023, with projections reaching 1.8B by 2050. New research highlights the growing global impact of #MASLD and the need for continued collaboration across the liver community.

Read the full article here: https://bit.ly/4gP2YnE

#TLM26

@liversmdpi.bsky.socialSep 21, 2026, 12:41 PM

📢 New Article in #LiversMDPI

🧬 Galla et al. tested a nutraceutical in a gut–pancreas–liver model.

🩺 It reduced lipid accumulation and increased bile acid production.

📖 Read More: www.mdpi.com/2673-4389/6/...

#MASLD #Nutraceuticals #Probiotics

@icon-plc.bsky.socialSep 21, 2026, 11:00 AM

Not all #MASLD biomarker signals are equal. Reducing liver fat is not the same as fibrosis stage, which is a stronger predictor of adverse outcomes including MASH and hepatocellular carcinoma. The most useful risk models need to distinguish these endpoints. https://ow.ly/1nM850ZJegO

@pippa-matt.bsky.socialSep 21, 2026, 7:49 AM

Congratulations to Motswedi Anderson & team from @ahri-news.bsky.social, @crick.ac.uk, @uclnews.bsky.social for a prize at the #COLDA meeting (Conference on Liver Disease in #Africa) - we studied the interplay between #HBV, #HIV, #Alcohol & #Metabolic factors ( #MASLD) in #LiverDisease.
🧪 #MedSky

@springermedicine.comSep 20, 2026, 3:15 PM

While the cardiovascular-kidney-metabolic syndrome framework recognizes #MASLD as a major manifestation, it does not incorporate hepatic staging into risk stratification.

A proposed extension of the framework seeks to change that.

👉️ buff.ly/GlzrSci

#CKM #MedSky

@tumorscholar.bsky.socialSep 19, 2026, 10:31 AM

Restoring liver glutamine suppresses inflammation and limits liver injury. These findings identify T cell glutamine metabolism as a key metabolic checkpoint and promising therapeutic target in MASLD.

#MASLD #LiverResearch #LiverSky #Hepatology
https://doi.org/10.1016/j.cmet.2026.08.018

@endocrinologyadv.bsky.socialSep 18, 2026, 3:51 PM

A proposed 2-step machine learning framework that distinguishes phenotype discovery from clinical validation may enable individualized risk prediction and personalized #care pathways for patients with #MASLD.
https://www.endocrinologyadvisor.com/news/machine-learning-precision-phenotyping-masld/

@asipath.bsky.socialSep 18, 2026, 3:40 PM

Calling all liver lovers! We are excited to announce the first virtual event for the Summer Liver Academy Meeting (SLAM) Community. Join us on October 15 for a fantastic talk from Dr. Zhenghui Jiang https://bit.ly/3V6iIet

#SLAM #LiverResearch #MASLD #ALD #Hepatology

@tumorscholar.bsky.socialSep 18, 2026, 8:17 AM

Zonated cholesterol sensing by SIRT2 drives MASLD-HCC

#MASLD #LiverResearch #LiverSky #Hepatology
https://doi.org/10.1016/j.cmet.2026.08.015

@maraaspinall.bsky.socialSep 18, 2026, 12:57 AM

IN THIS ISSUE
Finding #liverdisease hiding in plain sight
For people with cognitive deficits, most #pTau217 tests “work”
#AI that works in one species might not transfer to another

sensitiveandspecific.substack.com/p/a-powerful...

#sensitiveandspecific #diagnostics #alzheimers #MASLD #MASH

@pippa-matt.bsky.socialSep 17, 2026, 5:44 AM

Conference on #Liver Disease in #Africa is opening in Addis Ababa, #Ethiopia this morning. Liver #cancer & #metabolic liver disease being headlined as #PublicHealth & economic threats to the continent, overlapping with endemic viral #hepatitis B.
#COLDA #diabetes #MASLD #HBV #MedSky #LiverSky 🇪🇹🧪

Screenshot of COLDA program 9th conference on liver disease in AfricaSlide photograph: 'convergence of persistent viral hepatitis, rising incidence of metabolic dysfunction and alcohol related liver injury, all occuring within contexts of social and structural inequities'. Image from talk by Prof Wendy Spearman from the University of Cape Town.
@egastroenterology.bsky.socialSep 17, 2026, 3:04 AM

🦠 New in eGastroenterology

🧬Intestinal neutral ceramidase fuels MASH by reshaping microbiota and increasing 2-HHA, which suppresses AhR–FUT2 fucosylation.

🧱 #MASH #MASLD #Microbiome #GutLiverAxis

🔗https://doi.org/10.1136/egastro-2026-100417
🔗https://doi.org/10.1136/egastro-2026-100458

@liversmdpi.bsky.socialSep 16, 2026, 7:34 AM

📢 Editor’s Choice in #LiversMDPI

🧬 Pedersen et al. used untargeted proteomics on paired visceral adipose and liver biopsies in obesity, #MASLD and #MASH
🩺 Proteomes in both tissues were affected more by #obesity than MASLD severity

📖 More: brnw.ch/21x5kUD

#VisceralAdiposeTissue #LiverTissue

@newsen.bsky.socialSep 15, 2026, 5:41 PM

Understanding the Silent Threat of Fatty Liver Disease and Its Early Signs #USA #MASLD #Cranberry_Township #Fatty_Liver #Dr._Karen_Jerome

@lancetprimarycare.bsky.socialSep 15, 2026, 10:18 AM

🆕Gong Feng and colleagues for the GPS-MASLD Alliance present their Delphi consensus and recommendations to support management of #MASLD in #primarycare

Read the full Review ➡️ www.thelancet.com/journals/lan...

#openaccess #primaryhealthcare #generalpractice #medsky #familymedicine #liverdisease

Figure 3 from the Review, showing the primary care-centred practice workflow for assessment and follow-up of MASLD, based on the FIB-4 index. Details step 1, with initial assessments, and step 2, with repeat assessments.
Load more